TX2® Low Profile TAA Endovascular Graft

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 110 participants.

Also called NCT01151020

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 110 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01151020
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Germany, Italy, Japan, Sweden, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01151020. Allocation not applicable; no masking; primary purpose treatment. Start 2010-03 (registry gives no type); primary completion 2014-01 (actual). Results posted on 2016-02-29.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
TX2® Low Profile TAA Endovascular Graft
Acronym
TX2® LP
Condition
Aortic Aneurysm
Condition
Penetrating Ulcer
Condition
Vascular Disease
Intervention (Device)
Zenith® TX2® Low Profile TAA Endovascular Graft
Lead sponsor
Cook Research Incorporated (class: industry)

Record details

Record id
cardio:ct-nct01151020
Content hash
6b4ab021ae9953f83be34a83336791a39ff95b25e00a4b275360e43a53ea919c